Back
Citius Oncology 10K Form
Buy
67
CTOR
Citius Oncology
Last Price:
1.57
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CTOR News And Ratings
See the #1 stock for the next 7 days that we like better than CTOR
CTOR Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Citius Oncology Earnings Forecast
Key Citius Oncology Financial Ratios
- Per Share Earnings over the last 2 years have been positive in 0 years.
Citius Oncology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | CTOR |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CTOR Technical Analysis vs Fundamental Analysis
Buy
67
Citius Oncology (CTOR)
is a Buy
Is Citius Oncology a Buy or a Sell?
-
Citius Oncology stock is rated a Buy
The current Citius Oncology [CTOR] share price is $1.67. The Score for CTOR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.